Missing: Genetic Therapy's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Genetic Therapy's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Genetic Therapy
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Genetic Therapy is included in 2 Expert Collections, including Cancer.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Latest Genetic Therapy News
Dec 6, 2022
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on advanced autologous and allogeneic cell therapies for cancers. It also covers developments in ADCs and small molecules for multiple cancers. Few innovations for inflammatory diseases and infectious diseases have also been highlighted in this issue. Therapies which leverage nanotechnology and engineered nanoparticles for drug protection and drug design complement these innovations. Synthetic biology innovations around low cost gene synthesis and deployment of gene circuits have been featured as well. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Key Topics Covered: Tumor Microenvironment Targeted Therapies With An Improved Therapeutic Index Highly Selective Adc Platform One-Time Curative Gene Therapy for Scd Bluebird Bio - Investor Dashboard Polyclonal Therapy Against Solid Tumors Instil Bio, Inc. - Investor Dashboard Immuno-Onco Therapies Against Solid Tumors Car-T Cell Therapy With Enhanced Cell Proliferation Bellicum Pharmaceuticals - Investor Dashboard Off-The-Shelf Car T-Cell Therapy Off-The-Shelf Ebv-Targeting T-Cell Products Small Molecule With Advanced Absorption, Distribution, Metabolism, and Excretion Properties Zentalis Pharmaceuticals - Investor Dashboard Technology Modulating Multiple Cell Types Nanotechnology-Protected Enzymes to Survive in the Gastrointestinal Environment Enhancing Enzyme Delivery Through Nanotechnology Perseo Pharma - Investor Dashboard Single Administration Orphan Drug With Us Fast-Track Designation Vivet Therapeutics - Investor Dashboard Genetic Circuits That Provide Accurate Control Over Gene Programming Asimov - Investor Dashboard Anti Inflammatory Live Biotherapeutics for Atopic Dermatitis Siolta Therapeutics - Investor Dashboard Benefits of Quick Turnover and Error-Free Sequencing Eurofins Genomics Blue Heron - Investor Dashboard Metabolism Boosting Daily Wellness Supplements With Anti-Aging Benefits Nmn Causing Nad+ to Activate Sir2 Gene to Boost Metabolic Efficiency Eh - Investor Dashboard Rapid Assay Delivering Accurate Results Comparable to Laboratory Tests Fq - Investor Dashboard
Genetic Therapy Frequently Asked Questions (FAQ)
Where is Genetic Therapy's headquarters?
Genetic Therapy's headquarters is located at Gaithersburg.
What is Genetic Therapy's latest funding round?
Genetic Therapy's latest funding round is Acq - P2P.
Who are the investors of Genetic Therapy?
Investors of Genetic Therapy include Sandoz, Rho Ventures and Abingworth.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.